Ryght, a leader in real-time generative AI healthcare technology for clinical research, has announced that the prestigious Winship Cancer Institute of Emory University has joined its unique Ryght Research Network. This global network creates an AI digital twin of every research site worldwide. Distinguished academic institutions like Winship are leveraging Ryght’s AI platform and applications to revolutionize clinical trial processes and streamline workflows.
As part of one of Georgia’s largest and most comprehensive health systems, Winship Cancer Institute of Emory University is the only National Cancer Institute (NCI)-designated comprehensive cancer center in the state. Known for its renowned academic research, dedicated patient-centric physicians and staff, and
its mission to positively transform cancer care, Winship’s vision is aligned with that of Ryght to improve the outcomes of all patients with cancer. By joining the Ryght Research Network, Winship Cancer Institute brings to its constituents innovative AI solutions that are destined to enhance the depth and breadth of its clinical research and trial operations.
“We are thrilled to join the Ryght Research Network bringing state-of-the-art AI solutions to our patients and staff,” said Suresh Ramalingam, MD, FACP, FASCO, Executive Director of Winship Cancer Institute. “Our commitment to excellence in cancer research aligns perfectly with the goals of Ryght AI as we streamline our processes, accelerate access to potentially life-saving therapies, and bring the right studies to our patients in a timely manner.”
The Ryght Research Network leverages advanced generative AI capabilities to process site-specific and industry-wide data, delivering real-time insights that enable sponsors and CROs to identify the best sites for their trials, while empowering sites to make data-driven decisions that run the very best studies for their patients. By automating crucial tasks such as site selection, feasibility assessment, automated study budgeting and patient referrals, the network transforms traditional trial workflows into automated communication between sponsors and sites, while simplifying trial management and accelerated patient selection for all parties.
“Joining the Ryght Research Network demonstrates our dedication to improving on status quo for cancer clinical research,” said Madhusmita Behera, PhD, Chief Research Informatics Officer and Associate Director of Winship Data Sciences and Informatics. “We are committed to the adoption of cutting edge Artificial Intelligence in a thoughtful manner so that patients have access to trials that suit their needs.”
With over 400 active clinical trials, Winship physicians, researchers, and staff are destined to bring on more studies, but more importantly to assure that these trials enroll on time, thereby maximizing operational efficiency and scale.
“Innovation in how we view clinical trial operations is at the heart of what we do every day here at Ryght AI,” said Chadi Nabhan, MD, MBA, FACP, Chief Medical Officer and Head of Strategy at Ryght. “We are completely aligned with Winship Cancer Institute’s vision of improving the outcomes of all patients with cancer globally.”
Learn more at https://www.ryght.ai/.
About Ryght:
Ryght AI is transforming clinical research with a cutting-edge platform that includes an AI digital twin of every research site across the globe. This innovative approach empowers sponsors and CROs to significantly accelerate clinical trial study startup through faster site selection and streamlined feasibility workflows, all powered by advanced generative and agentic AI. Furthermore, Ryght’s SOC Type 2-compliant platform enhances efficiency by fostering seamless, real-time communication between sponsors, CROs, and research sites.
For more information, please visit www.ryght.ai. To discuss AI-powered clinical trial solutions or network membership for your site, CRO or biopharma company, please email sales@ryght.ai.
About Winship Cancer Institute of Emory University
Dedicated to discovering cures for cancer and inspiring hope, Winship Cancer Institute of Emory University is Georgia’s only National Cancer Institute-designated Comprehensive Cancer Center, a prestigious distinction given to the top tier of cancer centers nationwide for making breakthroughs against cancer. Winship is researching, developing, teaching and providing patients with novel and highly effective ways to prevent, detect, diagnose, treat and survive cancer. Cancer care at Winship includes leading cancer specialists collaborating across disciplines to tailor treatment plans to each patient’s needs; innovative therapies and clinical trials; comprehensive patient and family support services; and a care experience aimed at easing the burden of cancer. Winship is Where Science Becomes Hope.